Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Center of Martinique

About this trial

The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique. Predictive factors of poor prognosis will also be analyzed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult (≥18 years) patients,

Admitted to University Hospital of Martinique with subarachnoid hemorrhage of aneurysmal origin between 01/01/2013 and 31/12/2021,

Informed patient/next-of-kin/treating physician consent for research participation.

Disqualifiers

Other causes of subarachnoid hemorrhage of non-aneurysmal origin (traumatic, arteriovenous malformation, cerebral tumor, cerebral thrombophlebitis).

Trial population

Patients hospitalized in Martinique for subarachnoid hemorrhage of aneurysmal origin

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Usual patient care for patients hospitalized for subarachnoid hemorrhage of aneurysmal origin

    Other intervention

    During hospitalization (2013-2021), patients were managed after multidisciplinary consultation in accordance with national recommendations between resuscitators, neurosurgeons and neuroradiologists, depending on the severity of the initial management and the patient's comorbidities, either by interventional radiology, neurosurgery or medical treatment.

Treatment groups

122 Participants
are divided into 1 treatment group
Group A: SAH of aneurysmal origin in hospitalized patients in Martinique between 2013 and 20211 intervention

Trial outcomes

Primary outcomes

1

Evaluate mortality in patients hospitalized for subarachnoid hemorrhage of aneurysmal origin over a 9-year period (2013-2021) in Martinique.

Mortality of subarachnoid hemorrhage of aneurysmal origin.

Time frame
6 months

Secondary outcomes

1

Evaluate the clinical outcome of these patients.

Patient's clinical outcome (mortality, impairment of patient autonomy, impairment of patient's level of dependece), assessed with the modified Rankin score at discharge and at a distance from hospitalization (minimum delay: 2.5 years).

Time frame
6 months
2

Analyze the factors associated with a significant impairment of autonomy and/or dependence.

Predictive factors associated with significant impairment of patient autonomy and/or dependence (modified Rankin score = 4 or 5): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size

Time frame
6 months
3

Analyze the factors associated with death.

Predictive factors associated with death (modified Rankin score = 6): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size.

Time frame
6 months
4

Analyze the factors associated with a poor prognosis (death AND/OR significant impairment of autonomy/dependence).

Predictive factors associated with a poor prognosis (modified Rankin score ≥ 4: death AND/OR impaired patient autonomy and/or dependence): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.